Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
James Havranek
Washington University, Department: Genetics
Should you be removed from our database? Contact us at [email protected]. Read more below.
ProCure Life Sciences
Other : Intellectual property rights (e.g. royalties, patents, copyrights) from the awardee institution
The committee determined Dr. Havranek's personal financial relationship with ProCure Life Sciences, related to the above referenced research, creates a financial conflict of interest due to the following reasons:
• Dr. Havranek's personal financial relationship is directly related to the research because the study is evaluating the intellectual property (IP) that is licensed to ProCure Life Sciences
• Dr. Havranek is entitled to future royalties from the licensing of the IP, which is evaluated in the above listed research being conducted at WU
• The outcomes of the research could directly benefit ProCure Life Sciences
• Since Dr. Havranek owns equity in the company, he could directly benefit should the company’s equity value increase as a result of the research.
• His role as, as described below, could directly affect the study
A MOLECULAR TOOLKIT FOR SINGLE-MOLECULE PROTEIN SEQUENCING
The complete and quantitative analysis of proteomic inventory is crucial for identifying and measuring biomarkers, those proteins whose levels differ between diseased and unaffected tissues. The ability to identify medical problems as early as possible improves outcomes. The ability to determine phosphorylation state in this analysis can make even finer distinctions between the biologically relevant states of different samples. The molecules we propose to engineer for protein sequencing could enable proteomic analysis that has excellent dynamic range, is inherently quantitative, and is sensitive to amino acid phosphorylation state.
Filed on September 11, 2017.
Tell us what you know about James Havranek's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
James Havranek filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| James Havranek | Washington University | Conflict of Interest | ProCure Life Sciences | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.